Maneesh Gulati has more than 25 years of experience as a patent professional concentrating in the biologics, gene therapy, genomics, chemical, biotechnological, biomarker, biomaterials and mechanical fields.
Patent Portfolio Development
Maneesh’s practice involves the management and development of patent portfolios, including the drafting, filing and prosecution of patent applications. Maneesh has managed and actively prosecuted substantial patent portfolios with applications throughout the world and, in particular, those of start-ups, privately held companies, universities, and multiple Fortune 100 biotechnology companies. In doing so, he has managed and prosecuted portfolios protecting FDA approved drugs and biologics.
Due Diligence, Freedom to Operate and Landscape Reviews
Maneesh has further engaged in extensive freedom to operate analyses, patentability analyses, due diligence investigations, clearance searches, non-infringement and invalidity opinion drafting, and competitive landscape analyses for industry clients, venture groups, and emerging companies. For example, Maneesh has engaged in rendering an opinion related to pioneering antibody technologies, in assessing the patent landscape for FDA approved drugs and biologics, in assessing the patent landscape for numerous therapeutic targets, and in assisting in the diligence of a patent portfolio prior to an initial public offering.
Patent Term Extension
Maneesh has drafted and successfully obtained Patent Term Extension (PTE) for FDA approved products.
Licensing
Maneesh’s practice further involves advising clients on licensing strategies. He has significant experience drafting, revising and evaluating various agreements (e.g., Material Transfer Agreements, Confidentiality Agreements, Joint Development Agreements, Supply Agreements, Licensing Agreements, etc.). His experience in this regard has been critical in best positioning clients to preserve and secure intellectual property rights for technologies in which they invest substantial resources.
